Adaptimmune Therapeutics Plc ADR [ADAP] Stock sold by Insider Rawcliffe Adrian for $20244.0
Adaptimmune Therapeutics Plc ADR’s recent filing unveils that its Chief Executive Officer Rawcliffe Adrian unloaded Company’s shares for reported $20244.0 on Jan 17 ’24. In the deal valued at $0.67 per share,30,080 shares were sold. As a result of this transaction, Rawcliffe Adrian now holds 44,848 shares worth roughly $45296.48. Then, Bertrand William C JR […]
A company insider recently sold 30,080 shares of Adaptimmune Therapeutics Plc ADR [ADAP]. Should You Sale?
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Adaptimmune Therapeutics Plc ADR shares valued at $20,244 were sold by Rawcliffe Adrian on Jan 17 ’24. At $0.67 per share, Rawcliffe Adrian sold 30,080 shares. The insider’s holdings dropped to 44,848 shares worth […]
Understanding the Risks of Investing in Adaptimmune Therapeutics Plc ADR (ADAP)
Adaptimmune Therapeutics Plc ADR’s filing revealed that its Chief Executive Officer Rawcliffe Adrian unloaded Company’s shares for reported $20244.0 on Jan 17 ’24. In the deal valued at $0.67 per share,30,080 shares were sold. As a result of this transaction, Rawcliffe Adrian now holds 44,848 shares worth roughly $47090.4. Then, Bertrand William C JR sold […]
Adaptimmune Therapeutics Plc ADR [ADAP] Shares Rise 1.57 % on Thursday
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Adaptimmune Therapeutics Plc ADR shares valued at $20,244 were sold by Rawcliffe Adrian on Jan 17 ’24. At $0.67 per share, Rawcliffe Adrian sold 30,080 shares. The insider’s holdings dropped to […]
Analyzing Adaptimmune Therapeutics Plc ADR (ADAP) After Recent Trading Activity
In a filing, Adaptimmune Therapeutics Plc ADR revealed its Chief Executive Officer Rawcliffe Adrian unloaded Company’s shares for reported $20244.0 on Jan 17 ’24. In the deal valued at $0.67 per share,30,080 shares were sold. As a result of this transaction, Rawcliffe Adrian now holds 44,848 shares worth roughly $60993.280000000006. Then, Bertrand William C JR […]
ADAP Stock Sees Decline of Approximately -14.56% in Last Five Days
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Adaptimmune Therapeutics Plc ADR shares valued at $20,244 were sold by Rawcliffe Adrian on Jan 17 ’24. At $0.67 per share, Rawcliffe Adrian sold 30,080 shares. The insider’s holdings dropped to […]
Analyzing Adaptimmune Therapeutics Plc ADR (ADAP) After Recent Trading Activity
In a filing, Adaptimmune Therapeutics Plc ADR revealed its Chief Executive Officer Rawcliffe Adrian unloaded Company’s shares for reported $20244.0 on Jan 17 ’24. In the deal valued at $0.67 per share,30,080 shares were sold. As a result of this transaction, Rawcliffe Adrian now holds 44,848 shares worth roughly $65926.56. Then, Bertrand William C JR […]
An Analysis of Adaptimmune Therapeutics Plc ADR (ADAP)’s Potential Price Growth
Adaptimmune Therapeutics Plc ADR’s filing revealed that its Chief Executive Officer Rawcliffe Adrian unloaded Company’s shares for reported $20244.0 on Jan 17 ’24. In the deal valued at $0.67 per share,30,080 shares were sold. As a result of this transaction, Rawcliffe Adrian now holds 44,848 shares worth roughly $64581.119999999995. Then, Bertrand William C JR sold […]
